In response to the Ebola outbreak in West Africa, Nitritex has donated seven pallets of personal protection equipment (PPE), including disposable coveralls, aprons, and more than 200,000 gloves to protect the healthcare workers helping to save lives during this crisis.

Selected new technologies, products, and facilities from CPhI Worldwide 2014 are reviewed.

Carrying on from our weekly column to help you eliminate a number of tablet manufacturing problems and tablet tooling failures with a simple seven-step tool-care process, we look at the third step, Repair.

The agency cites deviations from CGMPs for the manufacture of APIs at the company?s Gujarat, India plant.

The Alios Biopharma acquisition strengthens J&J's infectious disease pipeline.

USP releases compendium of quality standards for compounded medicines.

ValiRx entered into a collaboration agreement with the Deutsches Krebsforschungzentrum cancer research center.

Catalent has acquired Micron Technologies, a provider of particle size engineering technologies.

Threshold Pharmaceuticals' anticancer drug TH-302 receives FDA Fast Track designation.

GE Healthcare and Takeda Pharmaceutical Company announced an alliance to develop therapeutic drugs in the field of hepatic fibrosis to treat various liver diseases.

AVEO enters into a research and exclusive option agreement with Ophthotech for tivozanib (AV-951) for the treatment of ocular diseases

The European Medicines Agency responds to the European Ombudsman?s letter regarding redacted documents.

Essentra has signed an agreement to acquire Clondalkin's Specialist Packaging Division for a cash consideration of approximately $455 million.

Consort announced that it has completed the acquisition of Aesica.

As the second part of this series, we look at the importance of ?assessing? the punches and dies to check their condition and how this step may help avoid any problems that may occur during tablet manufacture.

ANSM wants company data on the benefits and risks of using Avastin over Lucentis in the treatment of wet age-related macular degeneration.

Facility will provide manufacturing services for inhalation, liquids, topicals and oral solids dosage forms

Catalent Pharma Solutions announces additional packaging and storage space for highly potent and cytotocix drugs at Kansas City facility.

Capsugel gives lead users access to intrinsically enteric capsule technology and support services.

SGS Life Science Services has been awarded cGMP accreditation from AIFA for its analytical laboratory in Livorno, Italy.

The deal between the two companies will strengthen Perrigo's presence in Europe.

Roche announced it will spend 450 million Swiss Francs on a new manufacturing facility in Suzhou, China.

FDA releases guidance specifying its preferred unique facility identifier system.

FDA gives orphan drug designation to Merrimack Pharmaceuticals MM-141 for the treatment of pancreatic cancer.

M&A transactions accounted for nearly $15 billion more this year than for the same period a year ago.

Construction has started on Novo Nordisk's laboratories for diabetes research in Denmark.

MedImmune enters into an agreement to acquire the image analysis and data mining company.

AstraZeneca announced a partnership with Pharmacyclics and Janssen for combination trials of MEDI4736 (AstraZeneca) with Imbruvica (Pharmacyclics and Janssen) for the treatment of hematologic cancers.